4//SEC Filing
CHAO DAVID M 4
Accession 0001847903-24-000036
CIK 0001847903other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 5:10 PM ET
Size
9.3 KB
Accession
0001847903-24-000036
Insider Transaction Report
Form 4
CHAO DAVID M
Chief Administrative Officer
Transactions
- Award
Ordinary Shares
2024-02-01+37,500→ 292,874 total - Award
Share Option (right to buy)
2024-02-01+150,000→ 150,000 totalExercise: $8.01Exp: 2034-02-01→ Ordinary Shares (150,000 underlying) - Tax Payment
Ordinary Shares
2024-02-01$8.19/sh−9,503$77,830→ 283,371 total
Footnotes (4)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]The shares reported in this transaction represent Restricted Share Units ("RSUs") issued under the Centessa Pharmaceuticals plc Amended and Restated 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one Ordinary Share of the Issuer. The RSUs shall vest and be settled in four equal annual installments with the first such annual vesting being on February 1, 2025.
- [F3]Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs.
- [F4]1/48th of the shares subject to such option shall vest and become exercisable in equal monthly installments with the first installment vesting on March 1, 2024.
Documents
Issuer
Centessa Pharmaceuticals plc
CIK 0001847903
Entity typeother
Related Parties
1- filerCIK 0001861871
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 5:10 PM ET
- Size
- 9.3 KB